Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with advanced ...

The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...

An estimated 1 in 10 U.S. adults had overlapping heavy drinking and obesity conditions in 2023, a cross-sectional study found ...

The C-reactive protein-triglyceride-glucose index may be a useful biomarker for identifying individuals at elevated risk of ...

The CAR-PRISM trial enrolled patients with high-risk smoldering multiple myeloma as defined by the 20/2/20 model: plasma ...

Health Secretary Robert F. Kennedy Jr. has said that the U.S., under his leadership, is limiting the spread of measles better ...

The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically ...

As medical organizations, lawmakers, advocates -- and even the lead actor from "The Pitt" -- laud the reauthorization of the ...

Research in older adults linked daytime napping patterns -- in the morning or longer and more frequent naps -- to a ...

Zasocitinib, which is a potent and highly selective TYK2 inhibitor would be a good option for some of our patients who are ...

Plastics are a growing threat to human health, and we, as clinicians, are well-equipped to help protect our patients from ...

"Parents don't immunize their children or give them other routine care, and then the kids get sick and they might even die," ...